Hot flushes: what they are and what actually helps

Around three-quarters of women experience vasomotor symptoms during the menopause transition. For a substantial minority they persist for a decade or more, and they are among the most disruptive symptoms because they wreck sleep as well as days.

The mechanism is more specific than "hormones", and knowing it makes the treatment landscape make sense.

What is actually happening

Your hypothalamus maintains core temperature within a narrow band — the thermoneutral zone. Above the upper threshold you sweat and vasodilate; below the lower one you shiver and vasoconstrict.

Oestrogen withdrawal narrows that zone, sometimes to a fraction of a degree. Small changes in core temperature that would previously have gone unnoticed now cross the threshold and trigger a full heat-dissipation response: peripheral vasodilation, flushing, sweating, and often a chill afterwards as the body overshoots.

The upstream driver appears to be a population of hypothalamic neurons — the KNDy neurons, signalling through neurokinin B — which become hyperactive when oestrogen falls and which project to the thermoregulatory centre. That is not a footnote: it is the basis of an entire new drug class.

Why this explains the triggers

If the zone is narrow, small heat inputs matter. Which is why the classic triggers are what they are: hot drinks, alcohol, spicy food, warm rooms, tight clothing, stress, and rising ambient temperature.

It also explains night sweats. Core temperature naturally falls during sleep and then rises in the early hours; with a narrowed zone, that rise crosses the threshold. The 3am wake-up covers the timing.

What works, ranked by evidence

Hormone therapy is the most effective treatment for vasomotor symptoms by a clear margin, typically reducing frequency and severity substantially. For symptomatic women under 60 or within ten years of menopause, current guidance holds that benefits generally outweigh risks. Hormone therapy: what actually changed after the WHI covers the risk conversation properly.

Neurokinin-3 receptor antagonists are a newer non-hormonal class developed specifically from the KNDy mechanism. They target the pathway directly rather than replacing oestrogen, and trial results have been substantial. Availability and licensing vary by country; liver monitoring is required with some.

Certain SSRIs and SNRIs — notably paroxetine, venlafaxine and escitalopram — reduce hot flush frequency, at doses lower than those used for depression. Useful for women who cannot or prefer not to take hormones. Note that paroxetine interacts with tamoxifen, which matters for breast cancer patients.

Gabapentin has evidence, particularly for night-time symptoms, with sedation as both a side effect and, at night, an advantage.

Clonidine has modest evidence and is often poorly tolerated.

Cognitive behavioural therapy has real trial evidence. It does not reduce the number of flushes much; it substantially reduces how bothersome they are and improves sleep and mood. That is a legitimate outcome — the distress is a large part of the problem — and CBT is under-offered.

Hypnotherapy has surprisingly decent trial data in this specific application.

What has weak or no evidence

Black cohosh: inconsistent trial results and rare hepatotoxicity reports. Evening primrose oil: no good evidence. Most phytoestrogen supplements: mixed and generally weak, with soy isoflavone results varying partly by whether an individual can metabolise them to equol. Bioidentical compounded hormones: not tested for safety or consistency of dose, and not recommended by any major body — regulated body-identical preparations are a different and legitimate thing.

Vitamin E, dong quai, ginseng, and most of the supplement aisle: nothing convincing.

What helps practically

Layered clothing and natural fibres. Keeping the bedroom genuinely cool, with breathable bedding. A fan. Cool water to hand at night. Identifying and moderating your own triggers, which are individual — alcohol is the biggest for many people and irrelevant for others.

Paced breathing at the onset has some evidence for reducing intensity.

Weight, where relevant: higher BMI is associated with more frequent vasomotor symptoms in the transition — what actually happens to your body in midlife.

Exercise does not reliably reduce flush frequency in trials, but improves sleep, mood and everything else, which is not nothing.

Find your own triggers, because they are not the list

The trigger list above is a population list. Yours will be shorter and more specific, and identifying it is worth more than following general advice.

That requires a record, because flushes are frequent enough that memory blurs them and the relevant input often precedes the flush by an hour or more. Logging frequency and severity alongside alcohol, caffeine, room temperature, stress and sleep for a few weeks usually surfaces two or three reliable culprits.

The same record does a second job: it tells you whether a treatment worked. Symptoms fluctuate week to week for reasons unrelated to anything you did, and judging a new medication from four weeks of impressions is how people abandon things that were working.

Naked is built for both — tracking symptoms alongside everything that might be driving them, and giving you a before-and-after that is data rather than recollection. If you are going to have a conversation about HRT, that record is also the strongest thing you can bring to it.